Literature DB >> 19893577

The adenomatous polyposis coli-associated exchange factors Asef and Asef2 are required for adenoma formation in Apc(Min/+)mice.

Yoshihiro Kawasaki1, Shinnosuke Tsuji, Ken Muroya, Shiori Furukawa, Yoko Shibata, Masumi Okuno, Susumu Ohwada, Tetsu Akiyama.   

Abstract

Sporadic and familial colorectal tumours usually harbour biallelic adenomatous polyposis coli (APC)-associated mutations that result in constitutive activation of Wnt signalling. Furthermore, APC activates Asef and Asef2, which are guanine-nucleotide exchange factors specific for Rac1 and Cdc42. Here, we show that Asef and Asef2 expression is aberrantly enhanced in intestinal adenomas and tumours. We also show that deficiency of either Asef or Asef2 significantly reduces the number and size of adenomas in Apc(Min/+) mice, which are heterozygous for an APC mutation and spontaneously develop adenomas in the intestine. We observed that the APC-Asef/Asef2 complex induces c-Jun amino-terminal kinase-mediated transactivation of matrix metalloproteinase 9, and is required for the invasive activity of colorectal tumour cells. Furthermore, we show that Asef and Asef2 are required for tumour angiogenesis. These results suggest that Asef and Asef2 have a crucial role in intestinal adenoma formation and tumour progression, and might be promising molecular targets for the treatment of colorectal tumours.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19893577      PMCID: PMC2799213          DOI: 10.1038/embor.2009.233

Source DB:  PubMed          Journal:  EMBO Rep        ISSN: 1469-221X            Impact factor:   8.807


  17 in total

Review 1.  Angiogenesis as a therapeutic target.

Authors:  Napoleone Ferrara; Robert S Kerbel
Journal:  Nature       Date:  2005-12-15       Impact factor: 49.962

2.  Intestinal tumorigenesis is suppressed in mice lacking the metalloproteinase matrilysin.

Authors:  C L Wilson; K J Heppner; P A Labosky; B L Hogan; L M Matrisian
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

Review 3.  APC, signal transduction and genetic instability in colorectal cancer.

Authors:  R Fodde; R Smits; H Clevers
Journal:  Nat Rev Cancer       Date:  2001-10       Impact factor: 60.716

Review 4.  Mitogen-activated protein kinase pathways mediated by ERK, JNK, and p38 protein kinases.

Authors:  Gary L Johnson; Razvan Lapadat
Journal:  Science       Date:  2002-12-06       Impact factor: 47.728

5.  Interaction of phosphorylated c-Jun with TCF4 regulates intestinal cancer development.

Authors:  Abdolrahman S Nateri; Bradley Spencer-Dene; Axel Behrens
Journal:  Nature       Date:  2005-07-10       Impact factor: 49.962

Review 6.  Wnt signalling and the actin cytoskeleton.

Authors:  T Akiyama; Y Kawasaki
Journal:  Oncogene       Date:  2006-12-04       Impact factor: 9.867

Review 7.  Distinct role of macrophages in different tumor microenvironments.

Authors:  Claire E Lewis; Jeffrey W Pollard
Journal:  Cancer Res       Date:  2006-01-15       Impact factor: 12.701

Review 8.  Matrix metalloproteinase inhibitors and cancer: trials and tribulations.

Authors:  Lisa M Coussens; Barbara Fingleton; Lynn M Matrisian
Journal:  Science       Date:  2002-03-29       Impact factor: 47.728

9.  Mutated APC and Asef are involved in the migration of colorectal tumour cells.

Authors:  Yoshihiro Kawasaki; Rina Sato; Tetsu Akiyama
Journal:  Nat Cell Biol       Date:  2003-03       Impact factor: 28.824

10.  An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis.

Authors:  Enrico Giraudo; Masahiro Inoue; Douglas Hanahan
Journal:  J Clin Invest       Date:  2004-09       Impact factor: 14.808

View more
  20 in total

Review 1.  Cdc42 in oncogenic transformation, invasion, and tumorigenesis.

Authors:  Kristy Stengel; Yi Zheng
Journal:  Cell Signal       Date:  2011-04-16       Impact factor: 4.315

2.  p190RhoGEF (Rgnef) promotes colon carcinoma tumor progression via interaction with focal adhesion kinase.

Authors:  Hong-Gang Yu; Ju-Ock Nam; Nichol L G Miller; Isabelle Tanjoni; Colin Walsh; Lei Shi; Linda Kim; Xiao Lei Chen; Alok Tomar; Ssang-Taek Lim; David D Schlaepfer
Journal:  Cancer Res       Date:  2011-01-11       Impact factor: 12.701

3.  Amotl2 interacts with LL5β, localizes to podosomes and regulates postsynaptic differentiation in muscle.

Authors:  Tomasz J Proszynski; Joshua R Sanes
Journal:  J Cell Sci       Date:  2013-03-22       Impact factor: 5.285

4.  Peptidomimetic inhibitors of APC-Asef interaction block colorectal cancer migration.

Authors:  Haiming Jiang; Rong Deng; Xiuyan Yang; Jialin Shang; Shaoyong Lu; Yanlong Zhao; Kun Song; Xinyi Liu; Qiufen Zhang; Yu Chen; Y Eugene Chinn; Geng Wu; Jian Li; Guoqiang Chen; Jianxiu Yu; Jian Zhang
Journal:  Nat Chem Biol       Date:  2017-07-24       Impact factor: 15.040

5.  A member of the ETS family, EHF, and the ATPase RUVBL1 inhibit p53-mediated apoptosis.

Authors:  Kenzui Taniue; Takeaki Oda; Tomoatsu Hayashi; Masumi Okuno; Tetsu Akiyama
Journal:  EMBO Rep       Date:  2011-07-01       Impact factor: 8.807

6.  Temporal Profiling of Astrocyte Precursors Reveals Parallel Roles for Asef during Development and after Injury.

Authors:  Lesley S Chaboub; Jeanne M Manalo; Hyun Kyoung Lee; Stacey M Glasgow; Fengju Chen; Yoshihiro Kawasaki; Tetsu Akiyama; Chay T Kuo; Chad J Creighton; Carrie A Mohila; Benjamin Deneen
Journal:  J Neurosci       Date:  2016-11-23       Impact factor: 6.167

7.  CDC42 inhibition suppresses progression of incipient intestinal tumors.

Authors:  Ryotaro Sakamori; Shiyan Yu; Xiao Zhang; Andrew Hoffman; Jiaxin Sun; Soumyashree Das; Pavan Vedula; Guangxun Li; Jiang Fu; Francesca Walker; Chung S Yang; Zheng Yi; Wei Hsu; Da-Hai Yu; Lanlan Shen; Alexis J Rodriguez; Makoto M Taketo; Edward M Bonder; Michael P Verzi; Nan Gao
Journal:  Cancer Res       Date:  2014-08-11       Impact factor: 12.701

8.  Structural basis for the recognition of Asef by adenomatous polyposis coli.

Authors:  Zhenyi Zhang; Leyi Chen; Lei Gao; Kui Lin; Liang Zhu; Yang Lu; Xiaoshan Shi; Yuan Gao; Jing Zhou; Ping Xu; Jian Zhang; Geng Wu
Journal:  Cell Res       Date:  2011-07-26       Impact factor: 25.617

Review 9.  RhoGEFs in cell motility: novel links between Rgnef and focal adhesion kinase.

Authors:  N L G Miller; E G Kleinschmidt; D D Schlaepfer
Journal:  Curr Mol Med       Date:  2014-02       Impact factor: 2.222

Review 10.  Rho guanine nucleotide exchange factors: regulators of Rho GTPase activity in development and disease.

Authors:  D R Cook; K L Rossman; C J Der
Journal:  Oncogene       Date:  2013-09-16       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.